Literature DB >> 2908831

Zidovudine-induced hepatotoxicity.

G Dubin1, M N Braffman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2908831     DOI： 10.7326/0003-4819-110-1-85

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections.

Authors:  K E Nelson; D L Thomas
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 2.  Treatment of HIV infection. Tolerability of commonly used antiretroviral agents.

Authors:  D W Notermans; R van Leeuwen; J M Lange
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 3.  Zidovudine (Retrovir) update.

Authors:  A R Rachlis
Journal:  CMAJ       Date:  1990-12-01       Impact factor: 8.262

4.  Hepatitis C virus infection in a male homosexual cohort: risk factor analysis.

Authors:  O K Ndimbie; L A Kingsley; S Nedjar; C R Rinaldo
Journal:  Genitourin Med       Date:  1996-06

Review 5.  Zidovudine toxicity. Clinical features and management.

Authors:  A Rachlis; M M Fanning
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 6.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

7.  Use of zidovudine in human immunodeficiency virus-induced hepatitis.

Authors:  D L Wertheim; E Valderamma; V R Bonagura
Journal:  Clin Diagn Lab Immunol       Date:  1994-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.